Harry Ostrer MD

Clinical Cytogenetics, Clinical Genetics, Clinical Molecular Genetics, Molecular Genetic Pathology

Professor, Pathology; Genetics; Pediatrics, Albert Einstein College of Medicine

1300 Morris Park AvenueForchheimer 520ABronx, NY 10461
Phone+1 718-430-8605

Dr. Ostrer is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ostrer's full profile Already have an account?

Summary

Harry Ostrer, MD, is a medical genetics specialist based in Bronx, NY, with subspecialties in clinical cytogenetics, clinical genetics, clinical molecular genetics, and molecular genetic pathology. Ostrer completed a residency in pediatrics at Johns Hopkins University and graduated from Columbia University Vagelos College of Physicians and Surgeons and Massachusetts Institute of Technology. With expertise in cancer genetics, pediatric genetics, and disorders of sex development, Ostrer has published research in notable journals like Clinical Cancer Research and Nature Genetics. Recognized among America's Top Doctors and New York's Top Doctors by Castle Connolly, Ostrer was also involved in the AMP vs. Myriad Genetics Supreme Court case.

Education & Training

Johns Hopkins UniversityResidency, Pediatrics, 1981 - 1984
National Institutes of HealthMolecular Genetics, 1978 - 1981
Johns Hopkins UniversityResidency, Pediatrics, 1976 - 1978
Columbia University Vagelos College of Physicians and SurgeonsClass of 1976
Massachusetts Institute of TechnologyB.S., 1972

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

VA State Medical License 2026 - 2028
NY State Medical License 1990 - 2027
OK State Medical License 2025 - 2026
MA State Medical License 2011 - 2017
CT State Medical License 2011 - 2015
NJ State Medical License 2011 - 2013
FL State Medical License 1985 - 1998
MD State Medical License 1979 - 1991
American Board of Medical Genetics and Genomics Clinical Cytogenetics
American Board of Medical Genetics and Genomics Clinical Genetics
American Board of Pediatrics Pediatrics
American Board of Medical Genetics and Genomics Clinical Molecular Genetics and Genomics
Join now to see all

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2006-2014
Top Doctors: New York Metro Area Castle Connolly, 2006-2014
Successful plaintiff with standing, ruling in AMP vs. Myriad Genetics U.S. Supreme Court, 2013

Publications & Presentations

PubMed

Spatially defined microenvironmental niches are associated with clinical outcome and tumor ecosystem diversity in head and neck cancer.
Jianhong An, Erqiang Hu, Qunlun Shen, Jing Zhu, Jiye Zhu
Med. 2026-08-14
Association of Intratumoral Microbiota with Prognosis in Head and Neck Squamous Cell Carcinoma.
Shanye Yin, Lin Cheng, Erqiang Hu, Junpeng Li, Gujie Wu
Clinical Cancer Research. 2026-05-01
1 citations
A Polygenic Risk Score for Late Bladder Toxicity Following Radiotherapy for Non-Metastatic Prostate Cancer.
Manzur Farazi, Xin Yang, Carson J Gehl, Gillian C Barnett, Neil G Burnet
Cancer Epidemiology, Biomarkers & Prevention. 2025-05-02

Journal Articles

Germline variation at 8q24 and prostate cancer risk in men of European ancestry
Matejcic M, Saunders EJ, Dadaev T, Brook MN, Wang K, Sheng X, Olama AAA, et al, Nat Commun, 1/1/2018
Robust genomic copy number predictor of pan cancer metastasis
Pearlman A, Upadhyay K, Cole K, Loke J, Sun K, Fineberg S, Freedland SJ, Shao Y, Ostrer H, Genes and Cancer, 1/1/2018
Biallelic mutations in FLNB cause a skeletal dysplasia with 46,XY gonadal dysgenesis by activating Beta-catenin
Upadhyay K, Loke J, O V, Taragin B, Ostrer H, Clin Genet, 1/1/2018

Books/Book Chapters

Encyclopedia of Life Sciences
Chapter: Sex determination, male: genetics of
Ostrer HJohn Wiley and Sons, Chichester, United Kingom2017
Legacy: A Genetic History of the Jewish People
Ostrer HOxford University Press, New York, NY2012
Essentials of Medical Genomics
Chapter: Genetic testing
Ostrer HJohn Wiley and Sons, New York, NY2003

Lectures

We're All Mishpocha: The Shared Population Genetics of Ashkenazi, Sephardic and Middle Eastern Jews
San Francisco, CA - 1/1/2018
How mutations in signal transduction pathways can cause 46,XY gonadal dysgenesis
Kona, HI - 1/1/2018
Functional genomic approaches for understanding the consequences of genetic variation
Haifa, Israel - 1/1/2018

Other

46,XY disorders of sexual development (DSD) and 46,XY complete gonadal dysgenesis
Ostrer, H, GeneReviews
http://www.genetests.org
1/1/2008
Genetic and environmental causes of birth defects
Ostrer H
http://www.uptodate.com/contents/genetic-and-environmental-causes-of-birth-defects
UpToDate, Wolters Kluwer Health - 2013-04-01
Basic principles of genetic counseling for the obstetrical provider
Ostrer H
http://www.uptodate.com/contents/basic-principles-of-genetic-counseling-for-the-obstetrical-provider
UpToDate, Wolters Kluwer Health - 2012-04-30

Press Mentions

Do Jewish Genetic Diseases Increase the Risk of COVID-19?May 12th, 2020
Prostate Cancer: New, Quicker Test to Assess Metastasis RiskNovember 23rd, 2019
Faster, Cheaper Test Has Potential to Enhance Prostate Cancer EvaluationDecember 12th, 2018

Grant Support

Robust Predictor of Colon Cancer RiskMORGAN AND MENDEL GENOMICS, INC.2018–2025
Genomics And Predictive Modeling Of Prostate Cancer Heath DisparityNational Cancer Institute2011
Genome-Wide Study To Identify SNPS And Cnps Associated With Radiation InjuryNational Cancer Institute2010–2011
Genome-Wide Study To Identify SNPS And Cnps Associated With Radiation InjuryNational Cancer Institute2009
Mentorship Program In Prostate Cancer GeneticsNational Cancer Institute2001–2005